人血白蛋白治疗脑出血脑水肿85例临床疗效观察

摘要

Objective:To explore the clinical therapeutic effect of cerebral hemorrhage and encephaledema patients treated with human albumin.Methods:170 cerebral hemorrhage and encephaledema patients of our hospital were selected and randomly divided into control group and treatment group, with each group of 85 patients. The control group was given mannitol for dehydration and the treatment group was given extra human albumin on the basis of the method for control group;then the clinical therapeutic effects of the two groups were compared. Results:The scores for the degree of nervous functional defects of the both two groups after the treatment were lower that before the treatment;while the degree of nervous functional defects and clinical therapeutic effect of the treatment group were all better than that of control group. Conclusion:Human albumin has excellent clinical therapeutic effect on cerebral hemorrhage and encephaledema patients, and is especially applicable to those patients who are not suitable for conventional dehydrant or cannot get syndromes relieved after using conventional dehydrant.%目的：探讨人血白蛋白对脑出血脑水肿的临床治疗效果。方法：选择我院的脑出血脑水肿的170例患者，随机分为对照组和治疗组，每组85例。对照组使用甘露醇脱水，治疗组在对照组的基础上加用人血白蛋白，对比两组的临床治疗效果。结果：两组治疗后神经功能缺损程度评分均较治疗前低；治疗组治疗后神经功能缺损程度、临床效果均优于对照组。结论：人血白蛋白对脑出血脑水肿患者的临床治疗效果较好尤其适用于不能使用常规脱水剂或者使用常规脱水剂后症状不能减轻的患者。